Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.32 - $11.0 $147,264 - $194,700
17,700 Added 10.91%
180,000 $1.67 Million
Q2 2024

Aug 15, 2024

SELL
$7.24 - $12.53 $1.81 Million - $3.14 Million
-250,400 Reduced 60.67%
162,300 $1.51 Million
Q1 2024

May 07, 2024

BUY
$3.25 - $11.77 $1.29 Million - $4.69 Million
398,400 Added 2786.01%
412,700 $4.09 Million
Q4 2023

Feb 14, 2024

BUY
$1.84 - $4.82 $26,312 - $68,926
14,300 New
14,300 $46,000
Q2 2023

Aug 11, 2023

BUY
$7.51 - $15.0 $660,129 - $1.32 Million
87,900 Added 320.8%
115,300 $1.1 Million
Q1 2023

May 16, 2023

SELL
$10.23 - $17.14 $1.49 Million - $2.5 Million
-145,600 Reduced 84.16%
27,400 $301,000
Q4 2022

Feb 14, 2023

BUY
$13.96 - $20.4 $1.83 Million - $2.67 Million
130,800 Added 309.95%
173,000 $2.56 Million
Q3 2022

Nov 14, 2022

BUY
$17.85 - $26.95 $271,320 - $409,640
15,200 Added 56.3%
42,200 $806,000
Q2 2022

Aug 15, 2022

BUY
$16.33 - $22.2 $130,639 - $177,600
8,000 Added 42.11%
27,000 $575,000
Q1 2022

May 16, 2022

SELL
$14.38 - $22.79 $140,924 - $223,342
-9,800 Reduced 34.03%
19,000 $366,000
Q4 2021

Feb 14, 2022

BUY
$14.98 - $25.5 $271,138 - $461,550
18,100 Added 169.16%
28,800 $597,000
Q3 2021

Nov 15, 2021

SELL
$19.28 - $27.1 $1.5 Million - $2.11 Million
-77,900 Reduced 87.92%
10,700 $256,000
Q2 2021

Aug 11, 2021

BUY
$24.42 - $34.75 $2.16 Million - $3.08 Million
88,600 New
88,600 $2.42 Million

Others Institutions Holding ARQT

About Arcutis Biotherapeutics, Inc.


  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $861M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.